MedPath

INNOVENTRIC LTD

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Innoventric Trilliumâ„¢ Stent Graft Early Feasibility Study (EFS)

Not Applicable
Recruiting
Conditions
Tricuspid Regurgitation Functional
Tricuspid Regurgitation
Interventions
Device: Trilliumâ„¢
First Posted Date
2024-01-18
Last Posted Date
2025-03-07
Lead Sponsor
Innoventric LTD
Target Recruit Count
15
Registration Number
NCT06212193
Locations
🇺🇸

Cardiovascular Institute of Los Robles Health System, Thousand Oaks, California, United States

🇺🇸

Ascension St. John, Detroit, Michigan, United States

🇺🇸

Mayo Clinic Hospital (Rochester), Rochester, Minnesota, United States

and more 9 locations

Innoventric Trilliumâ„¢ Stent Graft First-in-Human (FIH) Study

Not Applicable
Active, not recruiting
Conditions
Tricuspid Regurgitation
Interventions
Device: Trilliumâ„¢
First Posted Date
2020-02-28
Last Posted Date
2025-03-07
Lead Sponsor
Innoventric LTD
Target Recruit Count
20
Registration Number
NCT04289870
Locations
🇧🇪

OLVZ Aalst, Aalst, Belgium

🇩🇪

Leipzig Heart Center, Leipzig, Germany

🇧🇪

ZNA, Antwerp, Belgium

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath